RGNX REGENXBIO Inc.: institutional ownership and insider trading
179 funds reported holding $565M of REGENXBIO Inc. in their latest 13F filings; in Q2 2026 funds net sold $3.99M, with 24 new positions and 34 funds selling out; over the last 12 months insiders bought $950K and sold $940K on the open market; over its last four quarters it reported revenue of $174M and net income of −$196M.
RGNX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $108M, net income $22.7M, EPS 0.43
- Quarter ended Mar 31, 2026: revenue $6.39M, net income −$90.1M, EPS -1.72
- Quarter ended Dec 31, 2025: revenue $30.3M, net income −$67.1M, EPS -1.30
- Quarter ended Sep 30, 2025: revenue $29.7M, net income −$61.9M, EPS -1.20
Famous investors holding RGNX
- Two Sigma (Two Sigma Investments): $8.02M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $9.04M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $8.54M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $5.76M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $3.08M, 0.0% of the portfolio
Largest institutional holders of RGNX
- BlackRock, Inc. (BLK) — $76.6M
- Redmile Group, LLC — $52.3M
- VANGUARD GROUP INC — $48.6M
- STATE STREET CORP (STT, STT-PG) — $35.6M
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $26.2M
- VANGUARD CAPITAL MANAGEMENT LLC — $25.2M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $23.4M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $17.0M
- AQR CAPITAL MANAGEMENT LLC — $16.5M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $16.2M
Recent RGNX insider trades
- Aug 27, 2026: Ciongoli Gregory Austin bought 102,603 shares ($950K)
- Jul 2, 2026: Pakola Steve sold 2,161 shares ($29.5K)
- Jul 1, 2026: Pakola Steve sold 56,333 shares ($689K)
- May 11, 2026: Pakola Steve sold 15,309 shares ($169K)
5%+ owners
- JPMORGAN CHASE & CO.: 5.3% (Schedule 13G, filed Oct 13, 2026)
- STATE STREET CORPORATION: 5.3% (Schedule 13G, filed May 12, 2026)
Who owns the most RGNX stock?
The largest institutional holders of REGENXBIO Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($76.6M), Redmile Group, LLC ($52.3M), VANGUARD GROUP INC ($48.6M).
Are insiders buying or selling RGNX?
Over the last 12 months insiders bought $950K and sold $940K of REGENXBIO Inc. stock on the open market (SEC Form 4).
Which famous investors own RGNX?
Two Sigma, Ken Griffin, D. E. Shaw, Izzy Englander, Renaissance Technologies.
What was RGNX's revenue last quarter?
REGENXBIO Inc. reported revenue of $108M for the quarter ended June 30, 2026, with net income of $22.7M.
Which ETFs hold RGNX?
7 ETFs and mutual funds hold it among their top 100 positions, including VMNFX, DLHAX, BBC, SBIO.